Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma

被引：9
作者：
Fleming, DR
Mangino, PB
机构：
来源：
SOUTHERN MEDICAL JOURNAL | 1997年 / 90卷 / 03期
关键词：
D O I：
10.1097/00007611-199703000-00022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：364 / 365
页数：2
相关论文
共 11 条
[1]  
BALLESTER O, 1986, BLOOD S1, V86, pA206
[2]   EFFECTIVE TREATMENT OF ADVANCED MULTIPLE-MYELOMA REFRACTORY TO ALKYLATING-AGENTS [J].
BARLOGIE, B ;
SMITH, L ;
ALEXANIAN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (21) :1353-1356
[3]  
BOWEN BC, 1995, AM J NEURORADIOL, V16, P61
[4]   A PROGRESSIVE PARKINSONIAN-SYNDROME DEVELOPING AFTER CHEMOTHERAPY AND RADIOTHERAPY FOR NON-HODGKINS-LYMPHOMA [J].
HOWELL, SJL ;
SAGAR, HJ .
MOVEMENT DISORDERS, 1994, 9 (03) :373-375
[5]   TREATMENT OF RENAL-FAILURE ASSOCIATED WITH MULTIPLE-MYELOMA - PLASMAPHERESIS, HEMODIALYSIS, AND CHEMOTHERAPY [J].
JOHNSON, WJ ;
KYLE, RA ;
PINEDA, AA ;
OBRIEN, PC ;
HOLLEY, KE .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (04) :863-869
[6]  
LENHARD RE, 1984, CANCER, V53, P1456, DOI 10.1002/1097-0142(19840401)53:7<1456::AID-CNCR2820530705>3.0.CO
[7]  
2-C
[8]  
LITTLEWOOD TJ, 1987, CANCER CHEMOTH PHARM, V19, P180
[9]  
Luque F A, 1987, Mov Disord, V2, P219, DOI 10.1002/mds.870020309
[10]  
PETERS W, 1986, J CLIN ONCOL, V4, P645
12